Coldstream Capital Management Inc Aerovate Therapeutics, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Aerovate Therapeutics, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 104 shares of AVTE stock, worth $278. This represents 0.0% of its overall portfolio holdings.
Number of Shares
104Holding current value
$278% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AVTE
# of Institutions
87Shares Held
30.9MCall Options Held
146KPut Options Held
269K-
Ra Capital Management, L.P. Boston, MA9.19MShares$24.6 Million0.39% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA3.76MShares$10.1 Million0.81% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA2.24MShares$6.01 Million1.35% of portfolio
-
Atlas Venture Life Science Advisors, LLC1.8MShares$4.82 Million1.32% of portfolio
-
Braidwell LP Stamford, CT1.44MShares$3.86 Million0.21% of portfolio
About Aerovate Therapeutics, Inc.
- Ticker AVTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,448,100
- Market Cap $65.5M
- Description
- Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...